Cefdinir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67877-543 -
Package NDC
67877-543-01 -
Package NDC
67877-543-38 -
Package NDC
67877-543-60 -
Application number
ANDA210220 -
SPL ID
88df7b4a-ada5-4fd3-8e16-48053abdf1b2 -
SPL set ID
18888955-4db3-4d0d-939f-eaaa5f2e0dc4 -
UNII
CI0FAO63WC -
RxCUI
200346
What the source publishes
- Labeler
- Ascend Laboratories, LLC
- Active ingredients
- Cefdinir
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cefdinir",
"splId": "88df7b4a-ada5-4fd3-8e16-48053abdf1b2",
"labels": [
{
"setId": "18888955-4db3-4d0d-939f-eaaa5f2e0dc4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18888955-4db3-4d0d-939f-eaaa5f2e0dc4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=18888955-4db3-4d0d-939f-eaaa5f2e0dc4"
}
],
"routes": [
"ORAL"
],
"labeler": "Ascend Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (67877-543-01)",
"package_ndc": "67877-543-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20210220"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (67877-543-38) / 10 CAPSULE in 1 BLISTER PACK (67877-543-33)",
"package_ndc": "67877-543-38",
"identifierStatus": "well-formed",
"marketing_start_date": "20210220"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (67877-543-60)",
"package_ndc": "67877-543-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20210220"
}
],
"productId": "67877-543_88df7b4a-ada5-4fd3-8e16-48053abdf1b2",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "67877-543",
"deaSchedule": null,
"genericName": "Cefdinir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CEFDINIR",
"strength": "300 mg/1"
}
],
"applicationNumber": "ANDA210220",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210220",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175488",
"M0003827"
],
"upc": [
"0367877543604"
],
"unii": [
"CI0FAO63WC"
],
"rxcui": [
"200346"
],
"spl_set_id": [
"18888955-4db3-4d0d-939f-eaaa5f2e0dc4"
],
"pharm_class_cs": [
"Cephalosporins [CS]"
],
"pharm_class_epc": [
"Cephalosporin Antibacterial [EPC]"
],
"manufacturer_name": [
"Ascend Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67877-543_88df7b4a-ada5-4fd3-8e16-48053abdf1b2"